Zacks Research upgraded shares of Uranium Royalty (NASDAQ:UROY – Free Report) from a hold rating to a strong-buy rating in a research report report published on Monday morning,Zacks.com reports.
Other research analysts have also issued research reports about the stock. Wall Street Zen lowered shares of Uranium Royalty from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Raymond James Financial raised shares of Uranium Royalty from a “market perform” rating to an “outperform” rating in a research note on Tuesday. Finally, Weiss Ratings raised shares of Uranium Royalty from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, March 12th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy”.
Read Our Latest Research Report on UROY
Uranium Royalty Trading Up 7.6%
Uranium Royalty (NASDAQ:UROY – Get Free Report) last released its quarterly earnings data on Tuesday, March 10th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.02. Uranium Royalty had a net margin of 7.70% and a return on equity of 0.01%. The business had revenue of $12.25 million for the quarter.
Institutional Trading of Uranium Royalty
A number of hedge funds and other institutional investors have recently made changes to their positions in UROY. Goldman Sachs Group Inc. raised its holdings in shares of Uranium Royalty by 25.4% in the first quarter. Goldman Sachs Group Inc. now owns 104,243 shares of the company’s stock valued at $183,000 after purchasing an additional 21,118 shares during the last quarter. Thompson Davis & CO. Inc. acquired a new stake in shares of Uranium Royalty in the second quarter valued at approximately $33,000. Vident Advisory LLC raised its holdings in shares of Uranium Royalty by 47.1% in the second quarter. Vident Advisory LLC now owns 1,480,151 shares of the company’s stock valued at $3,700,000 after purchasing an additional 474,030 shares during the last quarter. Corient Private Wealth LLC acquired a new stake in shares of Uranium Royalty in the second quarter valued at approximately $29,000. Finally, Accordant Advisory Group Inc raised its holdings in shares of Uranium Royalty by 0.4% in the third quarter. Accordant Advisory Group Inc now owns 2,450,607 shares of the company’s stock valued at $10,538,000 after purchasing an additional 8,905 shares during the last quarter. 24.19% of the stock is currently owned by institutional investors and hedge funds.
Uranium Royalty Company Profile
Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.
The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.
See Also
Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.
